Showing results (21-30 of 30) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 30 results.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 28, 2020
Recommendations for the use of next-generation sequencing (NGS) for patients with metastatic cancers: a report from the ESMO Precision Medicine Working GroupF Mosele, J Remon, J Mateo, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 7, 2024
ESMO Recommendations on clinical reporting of genomic test results for solid cancersJ van de Haar, P Roepman, F Andre, et al.
BMC Cancer|June 2, 2024
The TEOGIC study project: a comprehensive characterization of early onset gastrointestinal cancer in the Northern area of SpainR Vera, N Castro, I Labiano, et al.
ESMO Real World Data and Digital Oncology|February 6, 2026
ESMO Guidance for Reporting Oncology real-World evidence (GROW)L Castelo-Branco, A Pellat, D Martins-Branco, et al.
ESMO Open|December 3, 2025
Efficacy and safety of atezolizumab plus bevacizumab in MSI-like metastatic colorectal cancer: a multicenter, single-arm, phase II, open-label clinical trialE Elez, S Siena, A Sartore-Bianchi, et al.
ESMO Open|April 29, 2023
Establishment of patient-derived tumor organoids to functionally inform treatment decisions in metastatic colorectal cancerG Martini, V Belli, S Napolitano, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 7, 2025
ESMO Precision Oncology Working Group recommendations on the structure and quality indicators for molecular tumour boards in clinical practiceC B Westphalen, L Boscolo Bielo, P Aftimos, et al.
JCO Precision Oncology|August 9, 2018
Transcriptional subtyping and CD8 immunohistochemistry identifies poor prognosis stage II/III colorectal cancer patients who benefit from adjuvant chemotherapyW L Allen, P D Dunne, S McDade, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 19, 2026
ESMO Adaptation of Lines of Systemic Therapy (EnLiST): a consensus framework for standardising the designation of lines of therapy in solid tumoursK S Saini, M Koopman, D Martins-Branco, et al.
ESMO Open|March 4, 2025
Integrated clinico-molecular analysis of gastric cancer in European and Latin American populations: LEGACY projectR Dienstmann, E Ruiz-García, M Alsina, et al.
Pageof 3